SCL Science
SCL사이언스 · 246960
Health Care Pharmaceuticals · KOSDAQ
Market cap US$46.2M (₩63.7B)
Overview
SCL Science makes medical devices that stop bleeding during surgical and vascular procedures, its flagship product, InnoSEAL, is a hemostatic pad that bonds with blood proteins to control bleeding.
Hospitals and clinicians performing vascular interventions and abdominal surgeries are the primary users of its devices. Listed on KOSDAQ, Korea's tech and small-cap board, the company also runs two other business lines: a temperature-controlled logistics service for biological and pharmaceutical shipments, and a data-platform business offering AI-assisted medical-imaging and health-screening software.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$958K
- FY2024US$3.4M
- FY2025US$15.9M
Operating profit
- FY2023−US$2.9M
- FY2024−US$2.7M
- FY2025−US$2.5M
Net income
- FY2023−US$3.6M
- FY2024−US$2.7M
- FY2025−US$3M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?